December 2013 Issue of Renal And Urology News
The American College of Physicians came out against chronic kidney disease screening in asymptomatic adults who do not have risk factors.
The study, sponsored by a group representing radiation oncologists, concluded that urologists use IMRT more if their practices offer it.
In a study, it was associated with a 29% increased risk of death and/or heart attack or stroke.
Serum levels vary throughout the day, and higher phosphorus intake exaggerates the early afternoon rise in serum phosphorus.
Compared with subjects in the lowest tertile of net acid excretion, those in the middle and highest tertiles had a 3.0 times and 9.9 times ...
Men with a history of prostate cancer are at increased risk of melanoma.
As a venue for presenting important research on kidney disease to the world, Kidney Week never disappoints.
Radium-223 was approved in May 2013 for the treatment of mCRPC with symptomatic bone metastases and no visceral disease.
News in Brief
Study suggests benefit of adding of emetine dihydrochloride to treatment.
More than half of all venous thromboembolism events were diagnosed after patient discharge.
The drug, which was off the market for the past year and a half, is indicated for the dissolution of renal and vesical calculi of ...
Agency releases a video, a poster, and a pocket guide to help providers and patients prevent development of infectious complications in patients undergoing hemodialysis.
Improved understanding of biosynthesis mechanisms will lead to better diagnoses and treatments for steroid hormone production disorders.
Starting dialysis after conception, not before, may improve birth rates in women with end-stage renal disease.
Innovative approaches offer the potential for effective treatments to limited target areas with improved side effect profiles.
Compliance gurus bet there are at least a few things physicians are not doing to comply with HIPAA.
Pad tests described to date have only been evaluated in older, parous women.
Researchers observe a high rate of local disease control with increased progression-free survival.
It does not improve disease-specific or overall survival in intermediate-risk PCa patients compared with short-term suppression.
Infants aged one month or younger who experience acute kidney injury during hospitalization have a 31% death rate.
Researchers observed significant improvements in lipid parameters, blood glucose, and blood pressure.
A serum 25-hydroxyvitamin D level of 20 to 100 ng/mL has no significant association with kidney stone incidence.
Patients with this malignancy had a 73% prevalence of simple renal cysts.
Results show an increased risk of mortality and hospitalizations compared with late starts.
Early results from a small group of patients show a clinical success rate of 95%.
New findings point to a link between abdominal fat and kidney disease progression.
It may reduce urinary citrate excretion, which is associated with an elevated stone risk, according to researchers.
Women with diabetes have a higher prevalence of risk factors for chronic kidney disease than men.
Study demonstrated six- and 12-month survival rates of 58% and 49%, respectively.
Patients whose statins were held in the 24 hours before cardiac surgery had higher levels of kidney injury biomarkers.
Template-guided saturation prostate biopsies are no longer necessary when high-quality state-of- the-art mpMRI is available
Renal and Urology News Articles
- Intensive Blood Pressure Reduction Benefits CKD Patients
- Study: Ureterolithotripsy Best for Large Proximal Ureteral Stones
- Reducing Serum Phosphorus to Safer Target Range Ups Survival
- Post-RP Radiotherapy Benefits Selected Men With Elevated PSA
- Switch to an Iron-Based Binder Found to Improve Phosphorus Lowering
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)